Crossmark

Combating drug resistance in acute myeloid leukaemia by drug rotations: the effects of quizartinib and pexidartinib

Published Online: 2021-04-08

Published Print: 2021-12

Authors

Yang, Jingmei

Lindström, H. Jonathan G.

Friedman, Ran http://orcid.org/0000-0001-8696-3104
Funding

Funding for this research was provided by:

Cancerfonden (CAN 2018/362)
License Information

Text and Data Mining valid from 2021-04-08

Version of Record valid from 2021-04-08
More Information

Article History

Received: 15 November 2020

Accepted: 24 February 2021

First Online: 8 April 2021

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current